Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left

Adrien Al Wazzan1, Marion Taconne1, Virginie Le Rolle1

  • 1Department of Cardiology, University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France.

Insights

Researchers identified four clusters of hypertrophic cardiomyopathy patients, with two clusters showing higher ventricular arrhythmia risk. Left ventricular longitudinal strain analysis improves risk stratification for these arrhythmias.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Imaging Analysis

Background:

  • Ventricular arrhythmia (VA) prediction in hypertrophic cardiomyopathy (HCM) is clinically challenging.
  • Conventional imaging and clinical data offer limited risk stratification for VA in HCM.
  • Novel approaches are needed to better identify high-risk HCM patients.

Purpose of the Study:

  • To characterize the VA risk profile in HCM patients.
  • To integrate clinical, conventional imaging, and left ventricular longitudinal strain (LV-LS) data using clustering.
  • To identify distinct patient clusters with varying VA risk.

Main Methods:

  • Longitudinal follow-up of 434 HCM patients from two centers (mean 6 years).
  • Automatic extraction of mechanical and temporal LV-LS parameters alongside clinical/imaging data.
  • K-means clustering analysis of 287 features to identify patient subgroups.

Main Results:

  • Four distinct clusters were identified, with clusters 1 and 4 exhibiting higher VA rates (31% and 26% respectively).
  • Clusters differed significantly in LV mechanics, particularly myocardial deformation and temporal dispersion.
  • Cluster 4 showed the most severe phenotype, including LV/LA remodeling and impaired exercise capacity.

Conclusions:

  • Clustering LV-LS parameters in HCM patients reveals four groups with specific strain patterns and distinct rhythmic risk levels.
  • Automatic LV strain parameter analysis enhances VA risk stratification in HCM.
  • This approach offers a more refined understanding of VA risk in HCM patients.
Abstract